Patents
US 12364745 B2: Immunogenicity of a CpG-adjuvanted recombinant plague vaccine
- Granted
- 2025-07-22
- Filed
- 2023-06-29 application 18344780
- Type
- Utility · 15 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present disclosure relates to immunogenic compositions comprising at least one Yersinia pestis (Y. pestis) antigen, an aluminum salt adjuvant, and an oligonucleotide comprising an unmethylated cytidine-phospho-guanosine (CpG) motif. The immunogenic compositions are suitable for stimulating an immune response against Y. pestis in a subject in need thereof. The present disclosure also relates to kits and methods using the immunogenic compositions, or two separate compositions which together comprise the antigen, the aluminum salt adjuvant, and the oligonucleotide.
Source: PVGPATDIS, file of 2026-04-10 (ipg250722.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION 50 patents | US company or organization | Emeryville, CA | DYNAVAX TECHNOLOGIES CORP SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally | PVGPATDIS, file of 2026-04-10 |
| THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY 183 patents | US federal government | Not reported | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Robert Janssen | Palm Springs, CA | 9 | PVGPATDIS, file of 2026-04-10 | |
| David Novack | Oakland, CA | 4 | PVGPATDIS, file of 2026-04-10 | |
| Wai Kwan Chung | Hagerstown, MD | 1 | PVGPATDIS, file of 2026-04-10 | |
| Andrew M. Glenn | Germantown, MD | 1 | PVGPATDIS, file of 2026-04-10 | |
| Lucy A. Ward | Silver Spring, MD | 5 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/0291 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P31/04 | PVGPATDIS, file of 2026-04-10 |
| Y02A | Technologies for adaptation to climate change | Y02A50/30 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2024-01-30 | Assignment Assignment of assignor's interest | JANSSEN, ROBERT S. signed 2023-07-17 NOVACK, DAVID signed 2023-07-17 | DYNAVAX TECHNOLOGIES CORPORATION EMERYVILLE, CA | 66300/720 | ECORSEXC, file of 2026-09-25 |
| 2023-07-11 | Assignment Assignment of assignor's interest | GLENN, ANDREW signed 2023-07-05 WARD, LUCY signed 2023-07-05 CHUNG, WAI KWAN signed 2023-07-06 | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY FORT DETRICK, MD | 64208/356 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.